FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2565604178> ?p ?o ?g. }

• W2565604178 endingPage "593" @default.
• W2565604178 startingPage "579" @default.
• W2565604178 abstract "Differences between interferons have been evaluated for over 20 years. While randomized controlled trial (RCT) data is mainly used for assessments and strong data for causal inferences, it does not necessarily reflect everyday practice. Real-world data may provide additional information.To assess the results, quality, and representativeness of observational studies directly comparing interferons (IFNs) in RRMS.Medline and Embase were searched for observational studies comparing IFN-beta-1a 30 mcg IM (Avonex 1 ), IFN-beta-1a 44 mcg SC (Rebif 2 ) and/or IFN-beta-1b 250 mcg SC (Betaseron 3 ). Outcomes included annualized relapse rate (ARR), proportions relapse free, confirmed progression free, treatment persistence, and neutralizing antibodies rates (NABs) measured up to 5 years of treatment. Data was combined using random effects meta-analyses. Categorical values were analyzed using chi-squared and Mann-Whitney tests.Thirty-six studies examining 32,026 patients (72.5% females, age = 39.2 ± 3.7 years, disease duration = 5.6 ± 2.0 years) were identified. Thirty-three studies investigated IFN-beta-1a IM (N = 11,925), 30 IFN-beta-1a SC (N = 10,684) and 34 IFN-beta-1b SC (N = 9417). Baseline ARRs were similar (1.37 ± 0.35, 1.51 ± 0.27 and 1.55 ± 0.23, respectively; P = .101) as were EDSS scores (2.24 ± 0.39, 2.33 ± 0.30, 2.55 ± 0.38; P = .070) and >75% were naïve to IFNs. On treatment, ARRs were comparable (IFN-beta-1a IM 0.52 ± 0.27, IFN-beta-1a SC 0.51 ± 0.24, IFN-beta-1b SC 0.55 ± 0.23; P = .595). Proportions of relapse-free patients were similar between drugs (P > .05 for all data points), except that IFN-beta-1a SC was superior to IFN-beta-1b SC in years 3-5 (all P ≤ .001). After 1 year, EDSS scores were comparable; after 2 years, IFN-beta-1a IM and IFN-beta-1a SC incurred less disease progression than IFN-beta-1b SC (P < .02). Confirmed progression-free rates and persistence were similar over 5 years. Fewer patients developed NABs with IFN-beta-1a IM (4.7 ± 1.5%) versus IFN-beta-1a SC (21.4 ± 2.8%) (P < 0.001) or IFN-beta-1b SC (32.2% ± 3.3%) (P < .001).In this comprehensive meta-analysis of real-world studies in RRMS, IFN-beta-1a IM, IFN-beta-1a SC and IFN-beta-1b SC had similar clinical profiles. When selecting an IFN, practitioners should consider observational data in their decision making process." @default.
• W2565604178 created "2017-01-06" @default.
• W2565604178 creator A5017439960 @default.
• W2565604178 creator A5019568971 @default.
• W2565604178 creator A5072611143 @default.
• W2565604178 date "2017-01-11" @default.
• W2565604178 modified "2023-09-26" @default.
• W2565604178 title "Comparative effectiveness of interferons in relapsing–remitting multiple sclerosis: a meta-analysis of real-world studies" @default.
• W2565604178 cites W1502925188 @default.
• W2565604178 cites W1512495229 @default.
• W2565604178 cites W1529192025 @default.
• W2565604178 cites W1581887055 @default.
• W2565604178 cites W1666336517 @default.
• W2565604178 cites W1966341344 @default.
• W2565604178 cites W1973550674 @default.
• W2565604178 cites W1974743586 @default.
• W2565604178 cites W1982044564 @default.
• W2565604178 cites W1982594744 @default.
• W2565604178 cites W1983999022 @default.
• W2565604178 cites W1990918979 @default.
• W2565604178 cites W2000897932 @default.
• W2565604178 cites W2002097738 @default.
• W2565604178 cites W2008009277 @default.
• W2565604178 cites W2011324376 @default.
• W2565604178 cites W2011804082 @default.
• W2565604178 cites W2015734871 @default.
• W2565604178 cites W2017044005 @default.
• W2565604178 cites W2031915800 @default.
• W2565604178 cites W2033175786 @default.
• W2565604178 cites W2036774081 @default.
• W2565604178 cites W2053121650 @default.
• W2565604178 cites W2059101486 @default.
• W2565604178 cites W2059349666 @default.
• W2565604178 cites W2060143655 @default.
• W2565604178 cites W2061005334 @default.
• W2565604178 cites W2063984158 @default.
• W2565604178 cites W2069006533 @default.
• W2565604178 cites W2072295861 @default.
• W2565604178 cites W2075936324 @default.
• W2565604178 cites W2086149172 @default.
• W2565604178 cites W2089794196 @default.
• W2565604178 cites W2096569053 @default.
• W2565604178 cites W2099167011 @default.
• W2565604178 cites W2105490558 @default.
• W2565604178 cites W2114505662 @default.
• W2565604178 cites W2115989506 @default.
• W2565604178 cites W2122545833 @default.
• W2565604178 cites W2123700459 @default.
• W2565604178 cites W2126930838 @default.
• W2565604178 cites W2127220563 @default.
• W2565604178 cites W2129967156 @default.
• W2565604178 cites W2130355701 @default.
• W2565604178 cites W2136451286 @default.
• W2565604178 cites W2139367012 @default.
• W2565604178 cites W2140360882 @default.
• W2565604178 cites W2146853725 @default.
• W2565604178 cites W2147231626 @default.
• W2565604178 cites W2148766438 @default.
• W2565604178 cites W2149017348 @default.
• W2565604178 cites W2150487817 @default.
• W2565604178 cites W2151185538 @default.
• W2565604178 cites W2151340435 @default.
• W2565604178 cites W2158202057 @default.
• W2565604178 cites W2158488354 @default.
• W2565604178 cites W2162649471 @default.
• W2565604178 cites W2169098250 @default.
• W2565604178 cites W2169398435 @default.
• W2565604178 cites W2315123323 @default.
• W2565604178 cites W2316448135 @default.
• W2565604178 cites W2331354957 @default.
• W2565604178 cites W2415647615 @default.
• W2565604178 cites W2916040650 @default.
• W2565604178 cites W4210548604 @default.
• W2565604178 cites W4244267183 @default.
• W2565604178 cites W579820641 @default.
• W2565604178 doi "https://doi.org/10.1080/03007995.2016.1276895" @default.
• W2565604178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28027680" @default.
• W2565604178 hasPublicationYear "2017" @default.
• W2565604178 type Work @default.
• W2565604178 sameAs 2565604178 @default.
• W2565604178 citedByCount "19" @default.
• W2565604178 countsByYear W25656041782017 @default.
• W2565604178 countsByYear W25656041782018 @default.
• W2565604178 countsByYear W25656041782019 @default.
• W2565604178 countsByYear W25656041782020 @default.
• W2565604178 countsByYear W25656041782021 @default.
• W2565604178 countsByYear W25656041782022 @default.
• W2565604178 crossrefType "journal-article" @default.
• W2565604178 hasAuthorship W2565604178A5017439960 @default.
• W2565604178 hasAuthorship W2565604178A5019568971 @default.
• W2565604178 hasAuthorship W2565604178A5072611143 @default.
• W2565604178 hasConcept C126322002 @default.
• W2565604178 hasConcept C168563851 @default.
• W2565604178 hasConcept C203014093 @default.
• W2565604178 hasConcept C23131810 @default.
• W2565604178 hasConcept C2780640218 @default.
• W2565604178 hasConcept C2908698914 @default.
• W2565604178 hasConcept C2994247566 @default.

• next